New device can diagnose Covid-19 from saliva samples
The tabletop diagnostic yields results in an hour and can be programmed to detect variants of the SARS-CoV-2 virus.
The tabletop diagnostic yields results in an hour and can be programmed to detect variants of the SARS-CoV-2 virus.
Biological sensors developed by MIT spinout Glympse Bio could help clinicians make decisions for individual patients.
Specialized nanoparticles create a “breath signal” that could be used to diagnose pneumonia and other infectious or genetic diseases.
Company working with Sikes Lab to test feasibility of low-cost diagnostic that could be manufactured by the millions each day.
Hadley Sikes designs simple-to-use diagnostic devices that could benefit patients around the world.
Diagnostic platform CARMEN combines microfluidics with CRISPR-based detection technology SHERLOCK, and could one day be used for public health efforts.
Chemical engineer aims to create a test that can work in 10 minutes and doesn’t require specialized instruments or laboratory infrastructure.
MIT scientists Omar Abudayyeh and Jonathan Gootenberg explain the current state of Covid-19 testing, and how a CRISPR tool may help solve the supply problem.
Study shows that a simple urine test can reveal the presence of lung cancer in mice.
James Collins, Pablo Jarillo-Herrero, and Richard Milner have won top prizes for their work.
Smart materials change properties in response to specific DNA sequences; could be used in a variety of devices.
Noninvasive device could benefit patients with kidney disease, congestive heart failure, or dehydration.
MIT spinoff is changing the way mosquito-borne illnesses are diagnosed and aims to influence how public health officials react to disease outbreaks.
Ultra-low-power sensors carrying genetically engineered bacteria can detect gastric bleeding.
Modular blocks could enable labs around the world to cheaply and easily build their own diagnostics.